Organon & Co

Financials

Visión general Informes Estadísticas Dividendos

Activos totales 10.68 B10.96 B12.06 B13.1 B12.87 B Total de pasivos 12.45 B12.04 B12.13 B12.63 B12.12 B Capital total -1.51 B-892 M-70 M472 M752 M Total de pasivos y patrimonio neto 10.68 B10.96 B12.06 B13.1 B12.87 B Deuda total 9.13 B8.91 B8.76 B8.88 B8.64 B Deuda neta 8.4 B8.21 B8.07 B8.21 B8.07 B

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

OGN

Financials

Organon & Co

Noticias

AAD recomienda la crema VTAMA de Organon para dermatitis atópica pediátrica

Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note

Organon Takeover At $15? Probably Not, Here's Why (NYSE:OGN)

Dow Dips Over 250 Points: Investor Sentiment Declines, Greed Index Remains In 'Fear' Zone - Goldman Sachs

Morning News Wrap-Up 4/10/26: Today’s Biggest Stock Market Stories! - TipRanks.com

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Organon Jumps 25% As Report Cites $12 Billion Sun Pharma Offer

S&P Futures Waver With All Eyes on Key U.S. Inflation Data, U.S.-Iran Talks Awaited

Las acciones de Organon suben un 8,4% tras la oferta de 12.000 millones de dólares de Sun Pharma

Las acciones de Organon & Co alcanzan mínimos de 52 semanas en 5,76 dólares

Organon presenta datos de la crema VTAMA para dermatitis atópica en AAD

Las acciones de Organon & Co alcanzan mínimos de 52 semanas en 6,17 dólares